Birnbaum, Howard; Pike, Crystal; Banerjee, Ritesh; … - In: PharmacoEconomics 30 (2012) 4, pp. 323-336
<Emphasis Type="Bold">Background: Rheumatoid arthritis (RA) is a chronic autoimmune disease that often results in joint pain, inflammation and bone erosions. Perhaps the most notable change in RA treatment during the last decade is the advent of biologics, and, in particular, anti-tumour necrosis factor agents. Given...</emphasis>